Virtus LifeSci Biotech Clinical Trials ETF (BBC)
BBC is a passive ETF by Virtus Investment Partners tracking the investment results of the LifeSci Biotechnology Clinical Trials Index. BBC launched on Dec 16, 2014 and has a 0.79% expense ratio.
ETF Info
| ISIN | US26923G3011 |
|---|---|
| CUSIP | 26923G301 |
| Issuer | Virtus Investment Partners |
| Inception Date | Dec 16, 2014 |
| Region | North America (U.S.) |
| Category | Health & Biotech Equities |
| Leveraged | 1x |
| Index Tracked | LifeSci Biotechnology Clinical Trials Index |
| Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Blend |
Expense Ratio
BBC features an expense ratio of 0.79%, falling within the medium range.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: BBC vs. BBP, BBC vs. IBBQ, BBC vs. ARKG, BBC vs. NFLX, BBC vs. VOO, BBC vs. BBH, BBC vs. QQQ, BBC vs. LLY, BBC vs. XBI, BBC vs. IYH
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Virtus LifeSci Biotech Clinical Trials ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Virtus LifeSci Biotech Clinical Trials ETF had a return of 28.15% year-to-date (YTD) and 81.20% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 28.15% | 25.82% |
| 1 month | 9.18% | 3.20% |
| 6 months | 16.26% | 14.94% |
| 1 year | 81.20% | 35.92% |
| 5 years (annualized) | 2.71% | 14.22% |
| 10 years (annualized) | N/A | 11.43% |
Monthly Returns
The table below presents the monthly returns of BBC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 3.81% | 18.46% | -3.12% | -10.43% | 1.62% | -4.73% | 14.23% | -2.88% | -0.29% | 1.75% | 28.15% | ||
| 2023 | 10.58% | -9.56% | -12.29% | 5.00% | 5.69% | -1.50% | 0.52% | -10.85% | -8.61% | -8.99% | 9.85% | 25.08% | -1.80% |
| 2022 | -22.31% | -4.80% | -1.94% | -21.07% | -12.26% | 11.61% | 11.18% | 5.54% | -3.01% | 5.28% | -1.60% | -1.85% | -35.13% |
| 2021 | 6.07% | 3.39% | -5.53% | -1.30% | -5.29% | 4.00% | -11.59% | 8.13% | -4.27% | -2.93% | -8.49% | -5.10% | -22.31% |
| 2020 | -7.00% | -3.78% | -13.95% | 20.84% | 16.22% | 4.96% | -10.11% | 4.18% | -3.63% | -0.50% | 21.14% | 5.54% | 30.32% |
| 2019 | 7.86% | 6.59% | 6.63% | -2.50% | -4.61% | 8.75% | -3.35% | -4.80% | -10.12% | 10.73% | 22.04% | 18.21% | 63.81% |
| 2018 | 14.32% | 1.84% | -0.93% | -5.28% | 11.69% | -5.76% | -0.10% | 9.52% | -3.38% | -22.35% | 2.14% | -15.25% | -18.29% |
| 2017 | 7.77% | 10.79% | 5.50% | -2.42% | -7.37% | 14.59% | 0.83% | 14.12% | 5.46% | -4.58% | 1.56% | 1.74% | 56.12% |
| 2016 | -33.91% | -10.10% | 10.37% | 3.78% | 5.92% | -14.04% | 10.56% | 0.60% | 13.14% | -19.90% | 9.33% | -7.19% | -36.63% |
| 2015 | 3.79% | 7.92% | 5.68% | -8.61% | 19.30% | 1.17% | -0.13% | -13.86% | -15.34% | 3.83% | 15.66% | -7.84% | 5.25% |
| 2014 | 3.90% | 3.90% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of BBC is 54, suggesting that the investment has average results relative to other ETFs in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Virtus LifeSci Biotech Clinical Trials ETF provided a 0.26% dividend yield over the last twelve months, with an annual payout of $0.08 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.08 | $0.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.00 | $0.15 |
Dividend yield | 0.26% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.04% | 0.00% | 0.51% |
Monthly Dividends
The table displays the monthly dividend distributions for Virtus LifeSci Biotech Clinical Trials ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.08 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2017 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.30 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2015 | $0.15 | $0.15 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Virtus LifeSci Biotech Clinical Trials ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Virtus LifeSci Biotech Clinical Trials ETF was 72.73%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
The current Virtus LifeSci Biotech Clinical Trials ETF drawdown is 49.21%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -72.73% | Feb 9, 2021 | 685 | Oct 27, 2023 | — | — | — |
| -58.5% | Jul 20, 2015 | 328 | Nov 3, 2016 | 788 | Dec 23, 2019 | 1116 |
| -40.47% | Dec 26, 2019 | 57 | Mar 18, 2020 | 37 | May 11, 2020 | 94 |
| -16.61% | Jun 24, 2020 | 53 | Sep 8, 2020 | 57 | Nov 27, 2020 | 110 |
| -15.83% | Mar 20, 2015 | 29 | Apr 30, 2015 | 20 | May 29, 2015 | 49 |
Volatility
Volatility Chart
The current Virtus LifeSci Biotech Clinical Trials ETF volatility is 7.32%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.